Trends in Cardiovascular Medicine
Volume 15, Issue 4 , Pages 142-148 , May 2005

Local Cytokine Environments Drive Aneurysm Formation in Allografted Aortas

  • Koichi Shimizu

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Richard N. Mitchell, MD, PhD, Department of Pathology, or Koichi Shimizu, MD, PhD, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, NRB7, Boston, MA 02115, USA. Tel.: (+1) 617-525-4303; fax: (+1) 617-525-4380.
    • ,
  • Peter Libby
    • ,
  • Richard N. Mitchell

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Richard N. Mitchell, MD, PhD, Department of Pathology, or Koichi Shimizu, MD, PhD, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, NRB7, Boston, MA 02115, USA. Tel.: (+1) 617-525-4303; fax: (+1) 617-525-4380.

References 

  1. Amento EP, Ehsani N, Palmer H, Libby P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb. 1991;11:1223–1230
  2. Brady AR, Thompson SG, Fowkes FG, et al. Abdominal aortic aneurysm expansion: Risk factors and time intervals for surveillance. Circulation. 2004;110:16–21
  3. Brophy CM, Reilly JM, Smith GJ, Tilson MD. The role of inflammation in nonspecific abdominal aortic aneurysm disease. Ann Vasc Surg. 1991;5:229–233
  4. Corcoran ML, Stetler-Stevenson WG, Brown PD, et al. Interleukin 4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. J Biol Chem. 1992;267:515–519
  5. Curci JA, Liao S, Huffman MD, et al. Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest. 1998;102:1900–1910
  6. Dalton DK, Pitts-Meek S, Keshav S, et al. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 1993;259:1739–1742
  7. Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest. 2000;105:1605–1612
  8. Davis VA, Persidskaia RN, Baca-Regen LM, et al. Cytokine pattern in aneurysmal and occlusive disease of the aorta. J Surg Res. 2001;101:152–156
  9. Elser B, Lohoff M, Kock S, et al. IFN-gamma represses IL-4 expression via IRF-1 and IRF-2. Immunity. 2002;17:703–712
  10. Eriksson P, Jones KG, Brown LC, et al. Genetic approach to the role of cysteine proteases in the expansion of abdominal aortic aneurysms. Br J Surg. 2004;91:86–89
  11. Gacko M, Glowinski S. Cathepsin D and cathepsin L activities in aortic aneurysm wall and parietal thrombus. Clin Chem Lab Med. 1998;36:449–452
  12. Hallett JW. Management of abdominal aortic aneurysms. Mayo Clin Proc. 2000;75:395–399
  13. Hansson GK, Holm J, Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol. 1989;135:169–175
  14. Huaux F, Liu T, McGarry B, et al. Dual roles of IL-4 in lung injury and fibrosis. J Immunol. 2003;170:2083–2092
  15. Hujanen ES, Vaisanen A, Zheng A, et al. Modulation of M(r) 72,000 and M(r) 92,000 type-IV collagenase (gelatinase A and B) gene expression by interferons alpha and gamma in human melanoma. Int J Cancer. 1994;58:582–586
  16. Jaffer FA, O'Donnell CJ, Larson MG, et al. Age and sex distribution of subclinical aortic atherosclerosis: A magnetic resonance imaging examination of the Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2002;22:849–854
  17. Juvonen J, Surcel HM, Satta J, et al. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 1997;17:2843–2847
  18. Knox JB, Sukhova GK, Whittemore AD, Libby P. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation. 1997;95:205–212
  19. Koch AE, Haines GK, Rizzo RJ, et al. Human abdominal aortic aneurysms: Immunophenotypic analysis suggesting an immune-mediated response. Am J Pathol. 1990;137:1199–1213
  20. Krettek A, Sukhova GK, Libby P. Elastogenesis in human arterial disease: A role for macrophages in disordered elastin synthesis. Arterioscler Thromb Vasc Biol. 2003;23:582–587
  21. Kumar R, Dong Z, Fidler IJ. Differential regulation of metalloelastase activity in murine peritoneal macrophages by granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor. J Immunol. 1996;157:5104–5111
  22. Lanone S, Zheng T, Zhu Z, et al. Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. J Clin Invest. 2002;110:463–474
  23. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868–874
  24. Libby P, Sukhova G, Lee RT, Galis ZS. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J Cardiovasc Pharmacol. 1995;25(Suppl 2):S9–S12
  25. Longo GM, Xiong W, Greiner TC, et al. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest. 2002;110:625–632
  26. Newman KM, Malon AM, Shin RD, et al. Matrix metalloproteinases in abdominal aortic aneurysm: Characterization, purification, and their possible sources. Connect Tissue Res. 1994;30:265–276
  27. Propranolol Aneurysm Trial. Propranolol for small abdominal aortic aneurysms: Results of a randomized trial. J Vasc Surg. 2002;35:72–79
  28. Pyo R, Lee JK, Shipley JM, et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest. 2000;105:1641–1649
  29. Reed D, Reed C, Stemmermann G, Hayashi T. Are aortic aneurysms caused by atherosclerosis?. Circulation. 1992;85:205–211
  30. Reilly JM, Sicard GA, Lucore CL. Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease. J Vasc Surg. 1994;19:865–872
  31. Rohde LE, Arroyo LH, Rifai N, et al. Plasma concentrations of interleukin-6 and abdominal aortic diameter among subjects without aortic dilatation. Arterioscler Thromb Vasc Biol. 1999;19:1695–1699
  32. Satta J, Haukipuro K, Kairaluoma MI, Juvonen T. Aminoterminal propeptide of type III procollagen in the follow-up of patients with abdominal aortic aneurysms. J Vasc Surg. 1997;25:909–915
  33. Scherer PW. Flow in axisymmetrical glass model aneurysms. J Biomech. 1973;6:695–700
  34. Schneiderman J, Bordin GM, Engelberg I, et al. Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall: A possible mechanism for aneurysm expansion. J Clin Invest. 1995;96:639–645
  35. Schönbeck U, Sukhova GK, Gerdes N, Libby P. T(H)2 predominant immune responses prevail in human abdominal aortic aneurysm. Am J Pathol. 2002;161:499–506
  36. Scott RA, Vardulaki KA, Walker NM, et al. The long-term benefits of a single scan for abdominal aortic aneurysm (AAA) at age 65. Eur J Vasc Endovasc Surg. 2001;21:535–540
  37. Shapiro SD, Campbell EJ, Kobayashi DK, Welgus HG. Immune modulation of metalloproteinase production in human macrophages: Selective pretranslational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-gamma. J Clin Invest. 1990;86:1204–1210
  38. Shi GP, Sukhova GK, Grubb A, et al. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest. 1999;104:1191–1197
  39. Shimizu K, Shichiri M, Libby P, et al. Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas. J Clin Invest. 2004;114:300–308
  40. Shimizu K, Sugiyama S, Aikawa M, et al. Host bone-marrow cells are a source of donor intimal smooth-muscle-like cells in murine aortic transplant arteriopathy. Nat Med. 2001;7:738–741
  41. Sukhova GK, Zhang Y, Pan JH, et al. Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. J Clin Invest. 2003;111:897–906
  42. Sukhova GK, Wang B, Libby P, et al. Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice. Circ Res. 2005;96:368–375
  43. Tellides G, Tereb DA, Kirkiles-Smith NC, et al. Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature. 2000;403:207–211
  44. Thompson RW. Basic science of abdominal aortic aneurysms: Emerging therapeutic strategies for an unresolved clinical problem. Curr Opin Cardiol. 1996;11:504–518
  45. Thompson RW, Parks WC. Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann NY Acad Sci. 1996;800:157–174
  46. Wang H, Keiser JA. Hepatocyte growth factor enhances MMP activity in human endothelial cells. Biochem Biophys Res Commun. 2000;272:900–905
  47. Watanabe T, Shimokama T, Haraoka S, Kishikawa H. T lymphocytes in atherosclerotic lesions. Ann NY Acad Sci. 1995;748:40–55
  48. Xie B, Dong Z, Fidler IJ. Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages. J Immunol. 1994;152:3637–3644

 This study was supported by National Institutes of Health grant RO1 HL-43364 (PL, RNM), GM-67049 (RNM, KS, PL), HL-67249 (KS, RNM), HL-067283 (KS), and Roche Organ Transplantation Research Foundation grant award (KS), and Harvard Medical School BWH Fellowship Award (KS). The authors have no conflict of interest.

PII: S1050-1738(05)00057-5

doi: 10.1016/j.tcm.2005.05.003

Trends in Cardiovascular Medicine
Volume 15, Issue 4 , Pages 142-148 , May 2005

Article Tools

* Image Usage & Resolution